Pfizer and Astellas’ Xtandi is already approved to treat non-metastatic castration-resistant prostate cancer, thanks to data showing it […]
Back in January, Merck said Keytruda—its anti-PD-1 therapy—had missed the mark in small cell lung cancer, an area […]
The public would support a new deal for international NHS and social care staff, a survey commissioned by […]
AbstractObjectiveTo estimate and compare progression rates to type 2 diabetes mellitus (T2DM) in women with gestational diabetes mellitus […]
Like many others, in recent weeks I’ve stepped into various clinical roles to support the response to covid-19. […]
The medical research world is responding to the covid-19 pandemic at breathtaking speed. There has been a maelstrom […]
As questions swirl over equitable access to COVID-19 vaccines, Sanofi CEO Paul Hudson has laid out some of his […]
No one company can provide enough COVID-19 vaccine doses for the world, Moderna Therapeutics CEO Stephane Bancel says. […]
As Takeda folds in Shire, the Japanese pharma is looking into the future, which includes waves of blockbuster […]
As part of a randomized controlled trial, a team from Lawson Health Research Institute is the first in […]